Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05834920

Effects of Neurofeedback and Transcranial Pulse Stimulation on Attention

The present study aims to examine and compare the effectiveness of transcranial pulse stimulation and neurofeedback among adults who are weak in attention.

Recruiting

Interested in participating?

Request Info

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 20 years and above
  • Right-handed
  • Normal/corrected hearing and vision
  • Having basic literacy skills
  • Having sustained attention scores below the threshold

Exclusion criteria

  • Having medical history related to brain
  • Having mild cognitive impairment
  • Showing symptoms of depression and anxiety
  • Having intellectual disability based on IQ scores
  • Having diagnoses of any psychiatric or cognitive disorders besides attention deficit hyperactivity disorder (ADHD) inattentive and combined types
  • Having long-term history of smoking cigarettes
  • Engaged in alcohol and/or substance abuse
  • Having history of hemophilia or other blood clotting disorders or thrombosis
  • Having corticosteroid treatment within the last six weeks before first intervention
  • Having contraindications for MRI scanning

Treatment and study plan

transcranial pulse stimulation (TPS)

Device

Participants will be treated with the TPS device NEUROLITH (Storz Medical AG). Treatments will be administered for up to 12 sessions within 4 weeks, each session consisting of 6000 TPS pulses of 0.2 mJ/mm².

Neurofeedback

Device

Participants will engage in a neurofeedback game designed to increase the ratio of theta/beta frequency bands in electroencephalography measurement. This intervention will be delivered for up to 12 sessions within 4 weeks.

Primary outcomes

  1. Change from baseline in Conners' Continuous Performance Test 3rd Edition

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Conners' Continuous Performance Test (CPT) measures inattentiveness, impulsivity, sustained attention, and vigilance. Participants are required to push the spacebar when any letter, except "X", appears. Performances are measured in raw scores and standardized T scores. T scores between 45-54 indicate average performance, higher or lower scores indicate atypical performance.

  2. Change from baseline in gradCPT continuous performance test

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The GradCPT is a continuous performance test to measure sustained attention. It has been shown to reliably indicate attentional fluctuation over time. Participants are required to respond to frequently presented city scene and inhibit responses to infrequently presented mountain scene. The sequence of visual stimuli is presented with gradual transitions to minimize involuntary attention capture by abrupt stimulus onset and offset. The main outcome of interest is reaction times variability, with higher variability indicating poorer sustained attention.

Secondary outcomes

  1. Change from baseline in Stroop task

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Victoria version of the Stroop task is a validated means of measuring the ability to inhibit cognitive interference. Over three tasks of increasing difficulty level, participants are asked to identify colors as they appear on stimulus flash cards. These colors are randomly ordered either as dots, noncolor words, or noncorresponding color words. Performance is measured by reaction times and accuracy. Shorter reaction times and higher accuracy indicate better ability to inhibit cognitive interference.

  2. Change from baseline in General Health Questionnaire

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The General Health Questionnaire (GHQ) measures psychological well-being. It comprises 12 self-report questions, each assessing the severity of a mental problem over the past few weeks. Total scores range from 0 to 36 with a higher score indicating poorer psychological states.

  3. Change from baseline in Goal Orientation Scale

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Goal Orientation Scale measures how individuals interpret and respond to achievement situations. It comprises three subscales. The present study uses only the learning goal orientation subscale which consists of 5 self-report items measuring the desire to develop the self by acquiring new skills, mastering new situations, and improving one's competence. Total scores range from 5 to 35 with higher scores indicating greater learning goal orientation.

  4. Change from baseline in N-back task

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The N-back task measures working memory function. Participants are presented a sequence of numbers ranging from 0 to 9 one-by-one. For each, they are required to decide whether the current stimulus is the same as the one presented two trials ago. Performance is measured by reaction times and accuracy. Shorter reaction times and higher accuracy indicate better working memory.

  5. Change from baseline in Color Trails Test

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Color Trails Test (CTT) is used to assess attention shifting (i.e., the ability to alternate attention between two goals) and processing speed (i.e., the speed with which a cognitive operation is carried out). The test comprises two parts: CTT1 requires participants to connect a series of numbered circles that are randomly printed on a sheet of paper and CTT2 requires participants to connect numbered circles from 1 to 25 alternating between two colors (pink and yellow). Performance is measured by reaction times with faster reaction times indicating better flexibility and speed.

  6. Change from baseline in Attentional Control Scale

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Attentional Control Scale is a self-report measure of attentional control. It consists of two subscales which measure selective attention and attention shifting respectively. Total scores range from 20 to 80 with higher scores indicating better attentional control.

  7. Change from baseline in Rosenberg Self-esteem Scale

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Rosenberg Self-Esteem Scale is a 10-item self-report questionnaire which measures global self-esteem by measuring both positive and negative feeling about the self. Scores range from 10 to 40 with higher scores reflecting higher self-esteem.

  8. Change from baseline in Social Connectedness Scale

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Social Connectedness Scale comprises 8 self-report items measuring three aspects of belongingness: connectedness, affiliation, and companionship. Total scores range from 8 to 48 with higher scores indicating higher sense of social connectedness.

  9. Change from baseline in Hospital Anxiety and Depression Scale (HADS)

    Time frame: Baseline, week 4, week 8, week 12, week 16

    The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report questionnaire comprising two subscales which assess levels of anxiety and depression respectively. Total scores for each subscale range from 0 to 21 with higher scores indicating higher levels of anxiety or depression.

Study contacts

Contact information is provided by the study sponsor or research team.

Maria T Wijaya, PhD

CONTACT

[email protected]

(852) 3917-8927

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Apr 28, 2023
Registry last updated
Mar 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.